These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22831964)
21. Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia? Femminella GD; Ninan S; Atkinson R; Fan Z; Brooks DJ; Edison P J Alzheimers Dis; 2016; 51(4):1275-89. PubMed ID: 27060942 [TBL] [Abstract][Full Text] [Related]
22. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease. Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994 [TBL] [Abstract][Full Text] [Related]
23. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients. Camicioli RM; Bouchard TP; Somerville MJ Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534 [TBL] [Abstract][Full Text] [Related]
24. Features of Plasma Homocysteine, Vitamin B12, and Folate in Parkinson's Disease: An Updated Meta-Analysis. Liu Y; Gou M; Guo X J Integr Neurosci; 2023 Aug; 22(5):115. PubMed ID: 37735121 [TBL] [Abstract][Full Text] [Related]
25. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Rolinski M; Fox C; Maidment I; McShane R Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314 [TBL] [Abstract][Full Text] [Related]
26. Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients. Lamberti P; Zoccolella S; Iliceto G; Armenise E; Fraddosio A; de Mari M; Livrea P Mov Disord; 2005 Jan; 20(1):69-72. PubMed ID: 15390046 [TBL] [Abstract][Full Text] [Related]
27. Plasma Homocysteine and Serum Folate and Vitamin B Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453 [TBL] [Abstract][Full Text] [Related]
28. A retrospective study of Parkinson's disease in Southwest China 2021-2024: An age-based approach. Chen C; Zhang D; Chen F; Wu D; Chen W; Qin H; Hu Y Exp Gerontol; 2024 Oct; 195():112532. PubMed ID: 39068693 [TBL] [Abstract][Full Text] [Related]
29. Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Köseoglu E; Karaman Y Clin Biochem; 2007 Aug; 40(12):859-63. PubMed ID: 17532313 [TBL] [Abstract][Full Text] [Related]
30. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423 [TBL] [Abstract][Full Text] [Related]
31. Dietary intake of vitamins B6, B12 and folate in relation to homocysteine serum concentration in the adult Polish population - WOBASZ Project. Waśkiewicz A; Sygnowska E; Broda G Kardiol Pol; 2010 Mar; 68(3):275-82. PubMed ID: 20411451 [TBL] [Abstract][Full Text] [Related]
32. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis? Shargorodsky M; Boaz M; Pasternak S; Hanah R; Matas Z; Fux A; Beigel Y; Mashavi M Diabetes Metab Res Rev; 2009 Jan; 25(1):70-5. PubMed ID: 19065546 [TBL] [Abstract][Full Text] [Related]
33. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort. Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722 [TBL] [Abstract][Full Text] [Related]
34. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients. Tseng YL; Chang YY; Liu JS; Su CS; Lai SL; Lan MY J Neurol Sci; 2009 Sep; 284(1-2):36-9. PubMed ID: 19398115 [TBL] [Abstract][Full Text] [Related]
35. Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level. Shin HW; Sohn YH J Mov Disord; 2009 May; 2(1):33-6. PubMed ID: 24868350 [TBL] [Abstract][Full Text] [Related]
36. Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus. Wang T; Yuan F; Chen Z; Zhu S; Chang Z; Yang W; Deng B; Que R; Cao P; Chao Y; Chan L; Pan Y; Wang Y; Xu L; Lyu Q; Chan P; Yenari MA; Tan EK; Wang Q Aging (Albany NY); 2020 Aug; 12(15):15682-15704. PubMed ID: 32805719 [TBL] [Abstract][Full Text] [Related]
38. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194 [TBL] [Abstract][Full Text] [Related]
39. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital. Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818 [TBL] [Abstract][Full Text] [Related]
40. Parkinson's disease is associated with hippocampal atrophy. Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]